AIM Vaccine Co., Ltd. (HKG:6660)
Hong Kong
· Delayed Price · Currency is HKD 3.090
+0.090 (3.00%)
Mar 10, 2026, 3:37 PM HKT
AIM Vaccine Market Cap
AIM Vaccine has a market cap or net worth of 3.68 billion as of March 10, 2026. Its market cap has decreased by -48.15% in one year.
Market Cap
3.68B
Enterprise Value
5.45B
Revenue
1.38B
Ranking
n/a
PE Ratio
n/a
Stock Price
3.09
Market Cap Chart
Since October 6, 2022, AIM Vaccine's market cap has decreased from 20.15B to 3.68B, a decrease of -81.74%. That is a compound annual growth rate of -39.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 3.68B | -6.54% |
| Dec 31, 2025 | 3.94B | -47.05% |
| Dec 31, 2024 | 7.44B | -21.78% |
| Dec 29, 2023 | 9.51B | -67.02% |
| Dec 30, 2022 | 28.82B | 43.02% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Qyuns Therapeutics | 3.75B |
| TYK Medicines | 4.25B |
| Medtide | 3.18B |
| BioDlink International Company | 3.15B |
| Mirxes Holding Company | 4.37B |
| Shandong Boan Biotechnology | 4.41B |
| Viva Biotech Holdings | 4.56B |
| Beijing Luzhu Biotechnology | 4.73B |